Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 402

1.

Caffeine-induced psychosis.

Hedges DW, Woon FL, Hoopes SP.

CNS Spectr. 2009 Mar;14(3):127-9.

PMID:
19407709
2.

Optimal dosing of desvenlafaxine, new insights in gambling and anorexia, and caffeine-induced psychosis.

Hollander E.

CNS Spectr. 2009 Mar;14(3):116-7. No abstract available.

PMID:
19407706
3.

Caffeine and psychiatric symptoms: a review.

Broderick P, Benjamin AB.

J Okla State Med Assoc. 2004 Dec;97(12):538-42. Review.

PMID:
15732884
4.

Caffeine as a psychomotor stimulant: mechanism of action.

Fisone G, Borgkvist A, Usiello A.

Cell Mol Life Sci. 2004 Apr;61(7-8):857-72. Review.

PMID:
15095008
5.

[Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].

Härtel-Petri R, Rodler R, Schmeisser U, Steinmann J, Wolfersdorf M.

Psychiatr Prax. 2005 Jan;32(1):13-7. German.

PMID:
15633070
6.

Psychosis following excessive ingestion of energy drinks in a patient with schizophrenia.

Cerimele JM, Stern AP, Jutras-Aswad D.

Am J Psychiatry. 2010 Mar;167(3):353. doi: 10.1176/appi.ajp.2009.09101456. No abstract available.

PMID:
20194494
7.

Nifedipine-associated acute psychosis.

Kahn JK.

Am J Med. 1986 Oct;81(4):705-6.

8.

Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine.

Huang ZL, Qu WM, Eguchi N, Chen JF, Schwarzschild MA, Fredholm BB, Urade Y, Hayaishi O.

Nat Neurosci. 2005 Jul;8(7):858-9.

PMID:
15965471
9.

Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.

Grelotti DJ, Kanayama G, Pope HG Jr.

Am J Psychiatry. 2010 Jan;167(1):17-23. doi: 10.1176/appi.ajp.2009.08111695. Review.

PMID:
20068123
10.

Psychosis associated with clonazepam therapy for blepharospasm.

White MC, Silverman JJ, Harbison JW.

J Nerv Ment Dis. 1982 Feb;170(2):117-9.

PMID:
7057171
11.

Baclofen-induced psychosis.

Chawla JM, Sagar R.

Ann Pharmacother. 2006 Nov;40(11):2071-3. Epub 2006 Oct 17.

PMID:
17047139
12.

Caffeine as a neuroprotective adenosine receptor antagonist.

Dall'Igna OP, Souza DO, Lara DR.

Ann Pharmacother. 2004 Apr;38(4):717-8. Epub 2004 Feb 24. No abstract available.

PMID:
14982979
13.
14.

What is the mechanism whereby cannabis use increases risk of psychosis?

Luzi S, Morrison PD, Powell J, di Forti M, Murray RM.

Neurotox Res. 2008 Oct;14(2-3):105-12. doi: 10.1007/BF03033802. Review.

PMID:
19073418
15.

Transient psychotic relapse temporally related to ingestion of an "energy drink".

Menkes DB.

Med J Aust. 2011 Feb 21;194(4):206. No abstract available.

PMID:
21401467
16.
17.

Caffeine-induced psychiatric manifestations: a review.

Wang HR, Woo YS, Bahk WM.

Int Clin Psychopharmacol. 2015 Jul;30(4):179-82. doi: 10.1097/YIC.0000000000000076. Review.

PMID:
25856116
18.

Caffeine and the dopaminergic system.

Cauli O, Morelli M.

Behav Pharmacol. 2005 Mar;16(2):63-77. Review.

PMID:
15767841
19.

Persistent interferon-ß-1b-induced psychosis in a patient with multiple sclerosis.

Manfredi G, Kotzalidis GD, Sani G, Koukopoulos AE, Savoja V, Lazanio S, Girardi N, Tatarelli R.

Psychiatry Clin Neurosci. 2010 Oct;64(5):584-6.

PMID:
20939157
20.

Prolonged cocaine psychosis implies underlying major psychopathology.

Satel SL, Seibyl JP, Charney DS.

J Clin Psychiatry. 1991 Aug;52(8):349-50. No abstract available.

PMID:
1869499

Supplemental Content

Support Center